GlassScriptPhysician profile
Omar Almousalli
NPI 1134161904
$16,118.21
in general payments reported to CMS, 2019-2025
54 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,029 · 2020: $1,445 · 2021: $3,055 · 2022: $2,413 · 2023: $2,281 · 2024: $1,433 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,176.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,709.23 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,563.72 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,145.05 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $1,069.19 | 2019-2024 | Xarelto |
| Biotronik INC. | $939.26 | 2019 | |
| Abiomed | $891.09 | 2021-2025 | Impella |
| Abbott Laboratories | $818.02 | 2019-2025 | Jot Dx, Cardiomems |
| Merck Sharp & Dohme LLC | $815.15 | 2021-2025 | Verquvo, Capvaxive |
| Esperion Therapeutics, INC. | $753.38 | 2020-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $731.25 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $727.63 | 2019-2025 | Breztri, Farxiga, Brilinta |
| Boston Scientific Corporation | $663.66 | 2019-2025 | Watchman Access System, Synergy |
| Pfizer INC. | $484.77 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $436.79 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $379.72 | 2023-2025 | Lifevest |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $318.86 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Scpharmaceuticals INC. | $221.12 | 2023-2025 | |
| Novo Nordisk INC | $205.76 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $197.12 | 2022-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $180.76 | 2021-2023 | Arcalyst |
| Philips North America LLC | $173.15 | 2019-2025 | Epiq Cvx |
| Regeneron Healthcare Solutions, INC. | $167.03 | 2019 | |
| Vifor Pharma, INC. | $140.25 | 2019-2021 | |
| Globus Medical, INC. | $132.06 | 2025 | Senza |
| Medtronic Vascular, INC. | $123.43 | 2020 | |
| Medtronic, INC. | $110.12 | 2021-2024 | Symplicity G3, Onyx Frontier, Linq II |
| Kiniksa Pharmaceuticals International, Plc | $96.35 | 2024 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $95.46 | 2019-2021 | |
| Penumbra, INC. | $86.67 | 2025 | Indigo System |
| Lexicon Pharmaceuticals, INC. | $79.67 | 2024 | |
| Intuitive Surgical, INC. | $74.74 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $64.60 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $56.41 | 2019-2022 | |
| Cvrx, INC. | $55.61 | 2023-2024 | Barostim Neo System |
| Gilead Sciences, INC. | $47.57 | 2019 | |
| Stryker Corporation | $45.83 | 2025 | Clottriever Bold Catheter |
| Cardiovascular Systems INC. | $41.97 | 2019-2022 | |
| Angiodynamics, INC. | $35.48 | 2023 | Auryon Laser System 100-120 Vac |
| Chiesi USA, INC. | $33.78 | 2022 | |
| Daiichi Sankyo INC. | $29.95 | 2022 | |
| Heartflow, INC. | $24.02 | 2025 | |
| Covidien LP | $23.98 | 2019 | |
| Cmp Pharma, INC. | $18.68 | 2020 | |
| Koya Medical, INC. | $18.05 | 2025 | Dayspring, Koya Medical |
| Aegerion Pharmaceuticals, INC. | $17.61 | 2019 | |
| Kestra Medical Technology Services, INC. | $15.00 | 2024 | Assure Wcd |
| Cook Medical LLC | $14.69 | 2023 | Zilver Ptx |
| Inari Medical, INC. | $13.35 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medicure Pharma INC. | $12.60 | 2021 | |
| Bardy Diagnostics, INC. | $11.00 | 2020 | |
| Genzyme Corporation | $7.57 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Almousalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.